A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa

An International Expanded Access Clinical Programme With ZD1839 (IRESSATM) for Patients With Advanced Non-small Cell Lung Cancer (NSCLC) China Amendment 1: A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa

The primary objective is to describe the quality of life of long-term survivors who are not terminated from the EAP.

Inclusion Criteria:

• Provision of informed consent prior to any study specific procedures.
• Participated in the Iressa EAP in China.
• Diagnosed as NSCLC.
• Patients who started EAP at least 3 years before this study initiated and have not yet terminated from the EAP (active long-term survivors).
• Patients who consent to provide blood sample and available archival tumour tissue sample for EGFR gene testing (provision of tumour tissue sample is optional).

Exclusion Criteria:

• Patients who disagree to participate this study.
• Patients in whose medical objection was recorded to use the existing data from medical practice for scientific research.